<DOC>
	<DOCNO>NCT02237352</DOCNO>
	<brief_summary>The prevalence diabetes mellitus ( DM ) increase worldwide , suggest 45 % diabetic undiagnosed . DM induce kidney disease call diabetic nephropathy ( DN ) large single cause end-stage renal disease dialysis requirement . In South America prevalence DM chronic kidney disease increase , great disparity exist among country regard access dialysis treatment . It considerate Hispanic origin increase risk DM . The South Americans distinctive habit , culture , environment , behavior genetic background factor involve DN define yet . The early kidney lesion neoangiogenesis ( pathologic generation new blood vessel ) extracellular matrix expansion describe . The vascular endothelial growth factor A ( VEGF ) link angiogenesis , role VEGF DN elucidate yet . VEGF signal mainly VEGF receptor 2 ( VEGFR2 ) . VEGFR2 interact alphaV beta3 integrin ( AVB3 ) kidney . Additionally tenascin C express extracellular matrix . Tenascin C tenascin C/AVB3 complex also link angiogenesis , however role unveil yet DN . Investigators hypothesize VEGF signal tenascin C play important role DN VEGFR2 , AVB3 tenascin C interact . The purpose study characterize social , environmental biological factor implicate DN Ecuador define role VEGF signal tenascin C pathogenesis DN . Investigators propose study factor involve DN diabetic non-diabetic adult general population , without DN . In single time investigator evaluate demographic data , habit , personal family history survey . Investigators measure anthropometrics parameter blood pressure ; investigator quantify blood glucose , glycosylated hemoglobin A1c proteinuria . In addition investigator examine role tenascin C VEGF signal analyze paraffin embed kidney tissue , plasma urine sample . Characterizing factor involve DN Hispanic people key establish adequate strategy prevention , diagnosis treatment population . Furthermore elucidate role protein involve DN may offer valuable tool development new treatment .</brief_summary>
	<brief_title>Mechanisms Diabetic Nephropathy Ecuador</brief_title>
	<detailed_description>1 . Determinations social , environmental biological factor implicate diabetic nephropathy Ecuador Investigators study subject general population . Investigators contact community religious leader order invite adult subject general population participate study 10000 person enrol . After teach basic concept prevention diabetic nephropathy subject , investigator collect demographic data , house condition localization ( rural , urban around city ) , number people share home , education level , employment economical condition , personal health insurance , medical checkup history , toxic habit ( alcohol , cigarette abuse addictive substance ) physical exercise habit . Investigators collect personal family antecedent diabetes mellitus , diabetic nephropathy , hypertension , kidney disease , diabetes gestational , current treatment chronic disease . Investigators measure body weight ( Kg ) , height ( ) investigator calculate body mass index . Investigators also measure blood pressure , blood glucose , glycosylated hemoglobin , microalbuminuria proteinuria . Trained personnel fill person 's survey . Investigators supervise collect data 2 % sample . 2 . Role extracellular matrix proteins growth factor signal diabetic nephropathy 1 . Systemic urine study : protein involve diabetic nephropathy pathogenesis vascular endothelial factor A ( VEGF ) extracellular matrix protein tenascin C ( tenascin ) concentration measure commercially available kit plasma urine ( respectively ) . Samples obtain diabetic ( n : 20 ) without diabetic nephropathy ( n : 20 ) non-diabetic subject ( control ) general population ( n : 2000 ) . Determinations social , environmental biological factor complete aim 1 . 2 . Kidney tissue study : investigator determine role protein involve diabetic nephropathy , VEGF signal tenascin : I ) Paraffin embed kidney tissue obtain sample library pathology laboratory study . Slides non-diabetics ( n : 10 ) diabetic diabetic nephropathy ( n : 20 ) without diabetic nephropathy ( n : 10 ) collect . The role proteins involve diabetic nephropathy VEGF signal tenascin study immunohistochemistry proximity link assay . II ) Paraffin embed kidney slide diabetic diabetic nephropathy ( n : 12 ) , non-diabetic control ( n : 6 ) primary glomerulopathy minimal change disease , diabetic control without diabetic nephropathy ( n : 6 ) , study . Investigators recruit patient kidney biopsy indicate , schedule perform , medical doctor . After pathology diagnosis completion , remnant paraffin embed tissue use study . The role proteins involve diabetic nephropathy , VEGF signal tenascin study immunohistochemistry proximity link assay . Urine plasma collect prior kidney biopsy order measure protein concentration potentially useful biomarkers diabetic nephropathy ; VEGF tenascin level quantify . Patients inform signed consent require . Blood glucose measure blood glucose meter test strip . Glycosylated hemoglobin A1c microalbuminuria ( albumin/creatinine spot urine ) quantify use portable machine ( Siemens ) . In fast condition investigator consider normal blood glucose value &lt; 99 mg % , pre-diabetes 100 125 mg % diabetes ≥126 mg % . In non-fasting condition value blood glucose &gt; 200mg % consider diabetes . Investigators deem normal glycosylated A1c hemoglobin value &lt; 5.6 % , pre-diabetes 5.7 6.4 % diabetes ≥6.5 % . Investigators deem normal albuminuria value albumin/creatinine ratio &lt; 29mg/g , microalbuminuria value 30 299 mg/g macro-albuminuria value ≥300mg/g . Proteinuria also evaluate reactive urine strip . In case inconsistent result range value analysis repeat sample analyzed standard laboratory equipment technique . Investigators consider diabetic nephropathy persistent proteinuria associate diabetic retinopathy decrease endogen glomerular filtration rate ( subject without diagnosis kidney urinary tract disease ) . In Type 1 diabetic , diabetic nephropathy diagnose history diabetes longer 10 year prior onset proteinuria ; diabetic type 2 , proteinuria associate decrease glomerular filtration rate diagnosis time , investigator deem diabetic nephropathy . In paraffin embed kidney sample measure protein expression localization . Investigators use kit , primary secondary antibody commercially available perform immunohistochemistry proximity link assay . Investigators perform experiment cooperation pathologist . All subject recruit general population identify unique code . Number capital letter code place survey sample label M0001 ( M : city , number 0001 : person number 0001 ) . Data upload saved secure data base . Trained personnel charge handle data base . Investigators supervise data entry . An investigator least every 6 month randomly select 2 % survey match information upload database . Furthermore , investigator analyze report collect data survey even incomplete adjust analysis parameter incomplete one . Investigators use descriptive statistic tool describe group ( mean , standard deviation standard error median interquartile range ) . For group comparison , unpaired T test , Mann Whitney Fisher 's test use . ANOVA , Kruskal Wallis Chi Square test perform compare unmatched group ; quantify association two variable Pearson Spearman correlation test use . Simple multiple regression consider predict value variable . P value &lt; 0.05 deem significant . A sample general population calculate consider adult population 21-70 year old Ecuador .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<criteria>adult , age 21 70 year old , person able sign inform consent , diabetic without diabetic nephropathy , diabetic diabetic nephropathy , hospitalize , suffer acute disease , live home least 6 month contact . subject acute disease , subject metabolic compensation , person temporarily reside place contact , young 21 year old , old 70 year old .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Diabetic nephropathy</keyword>
	<keyword>Social Factors</keyword>
	<keyword>Biological Factors</keyword>
	<keyword>VEGF-A</keyword>
	<keyword>Tenascin C</keyword>
	<keyword>Disease characterization</keyword>
	<keyword>Mechanisms</keyword>
	<keyword>Kidney</keyword>
	<keyword>Chronic kidney disease</keyword>
	<keyword>Secondary nephropathy</keyword>
	<keyword>South America</keyword>
	<keyword>Hispanics</keyword>
	<keyword>Ecuador</keyword>
	<keyword>Biomarkers</keyword>
</DOC>